'Jjareuruk' Turns Jjajang Noodles at PC Bangs: Samyang Foods Partners with I-SENS PC Bang and Webtoon Artists
Predicted impact: Low
Collaboration menu and promotions are small marketing items for a mid-sized food company.
i-SENS아이센스
099190 · KOSDAQ · ₩099190 · 아이센스
₩15,730▼ ₩100 (0.63%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −11.93%
- Market cap
- ₩465B
- Enterprise value
- ₩572B
- P/E
- —
- P/B
- 1.4×
- Dividend yield
- 0.6%
- ROE
- −0.8%
- Net margin
- −0.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−43.0% from the high
₩14,000Today: ₩15,670 – ₩16,150₩27,600
Returns
- 1W−3.7%
- 1M−0.8%
- 3M−5.4%
- 6M−25.8%
- YTD−1.1%
- 1Y−11.9%
- Volume today
- 20,458
- 0.7× the 20-day average
- Traded today
- ₩324M
- Listed shares
- 29,573,613
- EPS (12 months)
- −₩92
- Earnings yield −0.6%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
- MomentumFlat-2.3% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Jul 31: buy ₩2.1B at the close (206.5% of 20-day average trading value)
On its 11 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 27.5% of trading value and pointed the same way 3 of 11 times.
- 2× KODEX KOSDAQ150 Leverage ₩1.8B
- -1× KODEX KOSDAQ150 Futures Inverse ₩130M
- 2× TIGER KOSDAQ150 Leverage ₩85M
- 2× RISE KOSDAQ150 Futures Leverage ₩23M
- -1× TIGER KOSDAQ150 Futures Inverse ₩6.1M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
i-SENS stock overview
i-SENS (아이센스, KRX: 099190) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops, manufactures and sells medical sensors and measuring instruments based on electrochemical and biosensor technology. Its shares closed at ₩15,730 on Oct 27, 2026, down 0.63% on the day, giving it a market value of ₩465B.
Key facts
- Market cap
- ₩465B
- Sector
- Medical & precision devices
- Latest price change
- −0.63%
- As of
- Oct 27, 2026
- Main business
- The company develops, manufactures and sells medical sensors and measuring instruments based on electrochemical and biosensor technology.
Quick answers about i-SENS
- What does i-SENS do?
- The company develops, manufactures and sells medical sensors and measuring instruments based on electrochemical and biosensor technology. Its main segments are blood glucose monitoring, which includes self-monitoring blood glucose meters, test strips and continuous glucose monitoring systems for people with diabetes and healthy individuals, and point-of-care testing (POCT), which includes electrolyte and gas analyzers and cartridges, and HbA1c analyzers for hospital use. Its customers include diabetes patients, healthcare workers and hospitals, with products used in intensive care units, operating rooms and emergency rooms.
- What is the market cap of i-SENS?
- The market capitalisation of i-SENS was ₩465B at the close on Oct 27, 2026.
- Who are the largest shareholders of i-SENS?
- According to the latest official filings, the largest reported holders are Cha Geun-sik (24.79%, as of Oct 31, 2025); Arecle (11.38%, as of Jan 8, 2025); Nam Hak-hyeon (6.99%, as of Oct 1, 2026).
- When is the next earnings report from i-SENS?
- Korean companies rarely announce results dates in advance. Based on when i-SENS filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own i-SENS?
- Yes. The National Pension Service held 0.41% of i-SENS shares as of Dec 31, 2025.
Company profile
The company develops, manufactures and sells medical sensors and measuring instruments based on electrochemical and biosensor technology. Its main segments are blood glucose monitoring, which includes self-monitoring blood glucose meters, test strips and continuous glucose monitoring systems for people with diabetes and healthy individuals, and point-of-care testing (POCT), which includes electrolyte and gas analyzers and cartridges, and HbA1c analyzers for hospital use. Its customers include diabetes patients, healthcare workers and hospitals, with products used in intensive care units, operating rooms and emergency rooms.
Written by AI from the company's latest annual report.
- Korean name
- 아이센스
- CEO
- 차근식, 남학현(각자 대표이사)
- Founded
- May 2000
- Listed
- Jan 2013
- Listed shares
- 29,573,613
- Fiscal year ends
- Month 12
- Website
- www.i-sens.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent news
Recent filings
See all- Insider shareholding reportOct 1, 2026
- Insider shareholding reportSep 21, 2026
- Adjustment of Conversion PriceAug 31, 2026
- Exercise of Conversion RightsAug 24, 2026
- Half-year report (Jun 2026)Aug 14, 2026
Titles in Korean until English translations are added.
Also known as: i-SENS / 아이센스 / 099190 / KRX:099190
Source: KRX statistical information